Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey Stein currently holds 54,281 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Stein has been a net buyer of CDTX stock. They have purchased $3.6M and sold $37.4K worth of shares.
Jeffrey Stein's most recent insider trade was on Mar 2, 2026, when they purchased 50,000 shares at $32.96 per share.
Jeffrey Stein serves as Executive at Cidara Therapeutics, Inc. (CDTX). They have executed 56 insider transactions totaling $3.7M over their tenure at the company.
Jeffrey Stein holds the position of Executive at Cidara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Jeffrey Stein has shown a buying trading pattern, with $3.6M in total purchases and $37.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jeffrey Stein was on Mar 2, 2026, when they purchased $1.6M worth of IDYA shares. This transaction involved 50,000 shares at $32.96 per share.
Jeffrey Stein currently owns 54,281 shares of Cidara Therapeutics, Inc. (CDTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey Stein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey Stein has 56 Form 4 filings on record as an insider at Cidara Therapeutics, Inc..
Set alerts for Jeffrey Stein and 40,000+ other insiders.